Intervention not reported
Any depression Multiple measures used. CES‐D (Blanchard 1996;McCorkle 2007). POMS Depression subscale (Bultz 2000). HADS‐D (Nicolaisen 2018; Robertson 2016). Higher scores indicate higher levels of depression. Folllow‐up: Three to six months post‐... · informal caregivers of people affected by cancer
1 finding from 1 review
All‐cause mortality Up to 28 days following admission · individuals with influenza
It is very uncertain whether corticosteroid therapy changes number of deaths at 30 days following admission (30‐day mortality)a compared with no corticosteroid therapy (very low certainty).
1 finding from 1 review
Health outcomes Peak expiratory flow readings (higher readings indicate better peak flow) · adults and children > 12 with non‐allergic rhinitis
It is very uncertain whether intranasal corticosteroids changes objective measurement of airflow: peak flow rate (expiratory) compared with placebo (very low certainty).
1 finding from 1 review
Stress Lower score better Short‐term cRCT
1 finding from 1 review
no estimate extracted
157 participants
Very low
Stress Lower score better Mid‐term CBA
1 finding from 1 review
no estimate extracted
357 participants
Low
Absenteeism
1 finding from 1 review
no estimate extracted
174 participants
Low
Stress Lower score better Short‐term cRCT
1 finding from 1 review
no estimate extracted
98 participants
Very low
Stress Lower score better Mid‐term CBA
2 findings from 1 review
no estimate extracted
304 participants
Very low
no estimate extracted
368 participants
Very low
Stress 1 month
1 finding from 1 review
no estimate extracted
145 participants
Very low
Absenteeism
1 finding from 1 review
no estimate extracted
164 participants
Very low
Sleep quality Assessed by average duration of slow‐wave and REM sleep periods · adults with obstructive sleep apnoea
1 finding from 1 review
Sleep quality Assessed by average duration of slow‐wave and REM sleep periods · adults with obstructive sleep apnoea
1 finding from 1 review
Intervention not reported
Disability Post‐treatment Lower scores indicate lower levels of disability · children or adolescents with mixed chronic pain conditions
1 finding from 1 review
Intervention not reported
Depression Post‐treatment Lower scores indicate lower levels of depression · children or adolescents with mixed chronic pain conditions
1 finding from 1 review
Intervention not reported
Anxiety Post‐treatment Lower scores indicate lower levels of anxiety · children or adolescents with mixed chronic pain conditions
1 finding from 1 review
Intervention not reported
Disability Post‐treatment Lower scores indicate lower levels of disability · children or adolescents with headaches
1 finding from 1 review
Intervention not reported
Depression Post‐treatment Lower scores indicate lower levels of depression · children or adolescents with headaches
1 finding from 1 review
Intervention not reported
Anxiety Post‐treatment Lower scores indicate lower levels of anxiety · children or adolescents with headaches
1 finding from 1 review
Intervention not reported
Pain intensity Post‐treatment Lower scores indicate lower levels of pain intensity · children or adolescents with mixed chronic pain conditions
1 finding from 1 review
Pharmacy user intermediate clinical outcomes e.g. cholesterol, glycated haemoglobin5 (Lower scores indicate a better outcome) · community pharmacy workers (examples pharmacists, counter assistants etc), community pharmacy users
1 finding from 1 review
no estimate extracted
3971 participants
Moderate